This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1559827609334980v1 3/6/458    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mann, R. Articles by Nichols, J. Search for Related Content Social Bookmarking                         What's this?

Management of Chronic Obstructive Pulmonary Disease

^* To whom correspondence should be addressed. E-mail: rebecca.mann{at}umassmed.edu.

	Abstract

Chronic obstructive pulmonary disease (COPD) is a complex disease currently affecting a large number of individuals across the world. Historically thought of as an older male disease, the prevalence in women is rising. Patients with COPD primarily suffer from dyspnea, decreased exercise capacity, and chronic cough, which are due to progressive airflow limitation. Although typically considered a respiratory disorder, COPD differs from asthma both in pathophysiology and treatment. The airway obstruction commonly encountered in COPD results from multiple pathophysiologic processes, some of which may be preventable and modifiable. The mainstays of treatment are bronchodilators, and as lung function declines, the importance of including lifestyle modifications becomes even more essential. National and international guidelines direct treatment and diagnosis and attempt to increase awareness and education on the proper care of patients with COPD.

First published on April 27, 2009, doi:10.1177/1559827609334980

American Journal of Lifestyle Medicine 2009;3:458.

A more recent version of this article appeared on November 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?